Dadgar D, Burnett P E, Choc M G, Gallicano K, Hooper J W
Analytical Department, Phoenix International Life Sciences, St Laurent (Montreal), Quebec, Canada.
J Pharm Biomed Anal. 1995 Feb;13(2):89-97. doi: 10.1016/0731-7085(94)00106-c.
Although some degree of consensus has been reached concerning the requirements for acceptable method validation, the procedures used to establish them vary significantly between laboratories. Also, issues arising from application of these requirements during validation and subsequent sample analysis need to be addressed. The purpose of this paper is to discuss application issues concerning prerequisites to method validation, and all validation criteria for evaluation of method reliability and overall performance. Other poorly addressed issues such as re-validation, cross-validation, partial sample volume, multicomponent analysis and reporting will also be discussed. Although many issues discussed are of a general nature, the scope of this presentation is primarily to address issues arising from the validation and routine application of chromatographic methods.
尽管在可接受的方法验证要求方面已达成一定程度的共识,但各实验室用于确定这些要求的程序差异很大。此外,在验证和后续样品分析过程中应用这些要求所产生的问题也需要加以解决。本文的目的是讨论有关方法验证前提条件的应用问题,以及评估方法可靠性和整体性能的所有验证标准。还将讨论其他一些较少涉及的问题,如重新验证、交叉验证、部分进样体积、多组分分析和报告等。虽然所讨论的许多问题具有普遍性,但本报告的范围主要是解决色谱方法验证和常规应用中出现的问题。